Spamdex - Spam Archive

Report spam

Send in your spam and get the offenders listed

Create a rule in outlook or simply forward the spam you receive to questions@spamdex.co.uk

Also in e.moneyandmarkets.com

New Products, Services, Gadgets

Having trouble viewing this email? View it online.
(Mike Burnick, associate editor of Martin's Ultimate Portfolio and editor of Ultimate Stock Options, is out today. Mandeep Rai, editor of Top Stocks Under $10, is filling in.)
Thursday, June 25, 2015
Money and Markets
YOUR BEST SOURCE FOR THE UNBIASED MARKET COMMENTARY YOU WON'T GET FROM WALL STREET
New Products, Services, Gadgets –
Knowing What's for Real
by Mandeep Rai

Dear ,

One of the exciting aspects of editing and selecting stocks for the Top Stocks Under $10 portfolio is discovering new services, products or procedures that can lead little-known companies to new heights and grand valuations.

To be sure, the under-$10 universe is a risky, volatile arena. Some stocks have a reason for being there – they just aren't very good companies. However, others are there because they have been unfairly hit due to some outside, non-company-specific news. Still others have a large number of outstanding shares, so the share price is naturally going to be lower than those with fewer outstanding shares. Others just haven't been noticed by the public yet and represent great opportunities to buy on the low.

Acquiring low-priced stocks can bring a multitude of profit opportunities. But it can also bring losses if you invest in shaky companies without doing due diligence. That's what makes this sector so exciting, especially for someone like me who enjoys nothing better than going over the numbers, product pipelines, internal executive hirings, capital raisings, planned joint ventures and other relevant events related to a particular company.

Protect Your Wealth!

My mission is to make sure YOU are prepared to protect your wealth and keep it growing even in the worst of times. And for a limited time, if you accept this risk-free offer to my Safe Money Report, you'll save a whopping 75 percent! Plus ... get immediate access to 4 special bonuses absolutely FREE! –Mike

Internal Sponsorship

A recent example is a biotech company by the name of TrovaGene Inc. (TROV). Many investors, including my subscribers, probably had never heard of it. But through my research, I saw potential, and gave my subscribers a buy recommendation on Feb. 6 at a price of below $5. And they were able to sell it this week for over $10.50, more than doubling their investment.

TROV has been working on its non-invasive urine tests that detect and monitor diseases like cancerous tumors, addressing a $5 billion unmet medical need. The company has been around since 1999 and listed on the Nasdaq in 2002, but it hasn't been able to earn revenue on new products just yet.

However, while I was monitoring the company closely, something grabbed my attention: All of a sudden, it offered more stock to investors in a secondary share offering. It came at an unusual time – its regular cash burn per quarter of $4 million to $5 million would have kept it going for at least another year with the $27 million or so on its balance sheet.


Click image for larger view

The seemingly unneeded cash, not consistent with its cash burn rate from the cash flow statement, was a clue as to where this company could be headed. Indeed, the company had more than 20 joint collaborations with institutes like the Robert H. Lurie Comprehensive Cancer Center of Northwestern University (Lurie Cancer Center) and the Northwestern Medicine Developmental Therapeutics Institute (NMDTI), something that helped validate its testing technology.

This was a clear signal to me that the company would be entering a new phase on its business cycle, which would mean funding for personnel, facilities and marketing to get the word out. After it raised the money, it also announced it was hiring a seasoned chief commercial officer — someone in charge of scaling, marketing and commercial strategy execution, which was another clue.


Click image for larger view

The stock had been heading steadily higher, and then when news hit of superior tumor-detection and monitoring results compared with the invasive biopsy alternative, the gains mounted. Additional joint collaborators came to the table to work with TROV, further validating its product.

Now, it's important to never get complacent, even with a stock that's done as well as this and which has created such a buzz in the market. That's why I thought it prudent to take profits after its amazing run-up in price. I'll keep an eye on developments and determine if there's a time to get back in.

I've mentioned above some of the clues that can help indicate whether a company of this type can head toward its full potential or if it is a candidate for disappointment. This is what I've found to be the most important with TROV, at least. Other companies need to be looked at within the context of their business, industry and operating dynamics:

 Joint ventures increasing as the company attracts more buzz in its community;

 In the context of increased joint ventures, is the company giving hints about an upcoming catalyst – i.e. a need for cash after being operational with the same raised equity and burn cycle for over a decade?

 Internal executive hires;

 Company test announcements: keeping a close eye – and skeptical mind – on results of internal and external product test results.

I've seen some other promising newcomers with other companies that I've added to my Top Stocks Under $10 portfolio. But I wanted to share with you the experience I've had with TROV to point out some of the things you should keep an eye on when investigating companies promising something new to the marketplace. Not all investors have the time for such comprehensive research, but it can help avoid disappointment.

Best wishes,

Mandeep Rai


The investment strategy and opinions expressed in this article are those of the author's and do not necessarily reflect those of any other editor at Weiss Research or the company as a whole.

Have comments? Tell Us!

Facebook Twitter Linkedin YouTube Pinterest

About Money and Markets
For more information and archived issues, visit moneyandmarkets.com
Money and Markets is a free daily investment newsletter published by Weiss Research, Inc. This publication does not provide individual, customized investment or trading advice. All information is based upon data whose accuracy is deemed reliable, but not guaranteed. Performance returns cited are derived from our best estimates, but hypothetical as we do not track actual prices of customer purchases and sales. We cannot guarantee the accuracy of third party advertisements or sponsors, and these ads do not necessarily express the viewpoints of Money and Markets or its editors. For more information, see our Terms and Conditions. View our Privacy Policy. Would you like to unsubscribe from our mailing list? To make sure you don't miss our urgent updates, just follow these simple steps to add Weiss Research to your address book.

Attention editors and publishers! Money and Markets teaser content may be republished with a link to the full story on MoneyandMarkets.com. Such republication must include attribution with a link to the MoneyandMarkets home page as follows: "Source: moneyandmarkets.com"

Money and Markets: A Division of Weiss Research, Inc. |

4400 Northcorp Parkway | Palm Beach Gardens, FL 33410 | 1-800-393-0189

---------------------------

All titles, content, publisher names, trademarks, artwork, and associated imagery are trademarks and/or copyright material of their respective owners. All rights reserved. The Spam Archive website contains material for general information purposes only. It has been written for the purpose of providing information and historical reference containing in the main instances of business or commercial spam.

Many of the messages in Spamdex's archive contain forged headers in one form or another. The fact that an email claims to have come from one email address or another does not mean it actually originated at that address! Please use spamdex responsibly.


Yes YOU! Get INVOLVED - Send in your spam and report offenders

Create a rule in outlook or simply forward the junk email you receive to questions@spamdex.co.uk | See contributors

Google + Spam 2010- 2017 Spamdex - The Spam Archive for the internet. unsolicited electric messages (spam) archived for posterity. Link to us and help promote Spamdex as a means of forcing Spammers to re-think the amount of spam they send us.

The Spam Archive - Chronicling spam emails into readable web records index for all time

Please contact us with any comments or questions at questions@spamdex.co.uk. Spam Archive is a non-profit library of thousands of spam email messages sent to a single email address. A number of far-sighted people have been saving all their spam and have put it online. This is a valuable resource for anyone writing Bayesian filters. The Spam Archive is building a digital library of Internet spam. Your use of the Archive is subject to the Archive's Terms of Use. All emails viewed are copyright of the respected companies or corporations.

Our inspiration is the "Internet Archive" USA. "Libraries exist to preserve society's cultural artefacts and to provide access to them. If libraries are to continue to foster education and scholarship in this era of digital technology, it's essential for them to extend those functions into the digital world." This is our library of unsolicited emails from around the world. See https://archive.org. Spamdex is in no way associated though. Supporters and members of http://spam.abuse.net Helping rid the internet of spam, one email at a time. Working with Inernet Aware to improve user knowlegde on keeping safe online. Many thanks to all our supporters including Vanilla Circus for providing SEO advice and other content syndication help | Link to us | Terms | Privacy | Cookies | Complaints | Copyright | Spam emails / ICO | Spam images | Sitemap | All hosting and cloud migration by Cloudworks

Important: Users take note, this is Spamdex - The Spam Archive for the internet. Some of the pages indexed could contain offensive language or contain fraudulent offers. If an offer looks too good to be true it probably is! Please tread, carefully, all of the links should be fine. Clicking I agree means you agree to our terms and conditions. We cannot be held responsible etc etc.

The Spam Archive - Chronicling spam emails into readable web records

The Glass House | London | SW19 8AE |
Spamdex is a digital archive of unsolicited electronic mail 4.9 out of 5 based on reviews
Spamdex - The Spam Archive Located in London, SW19 8AE. Phone: 080000 0514541.